| Predicate |
Object |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-09 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-09 |
| filingDate |
2000-05-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2001-03-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e4c650573ecd3a4f1aae4cda3a0aae6e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7bd5b0060b8b099c6fb26df18ca6ee39 |
| publicationDate |
2001-03-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-6197337-B1 |
| titleOfInvention |
Therapeutic uses of abarelix |
| abstract |
A method of decreasing atherosclerosis and its complications including but not limited to myocardial infarction, stroke and peripheral vascular disease wherein the method involves administering to a human or an animal an amount of abarelix sufficient to reduce atherosclerosis and its complications. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004253266-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003144203-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03053219-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6479063-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03053219-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7169768-B1 |
| priorityDate |
1999-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |